# Marex Group Limited (MRX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Financial Services / Capital Markets. Price $78.27, market value $5.6 billion.

## Valuation
- **P/E (trailing): 15.9×** (5-yr avg 10.5×, 3-yr avg 10.5×). Marex Group Limited trades at 15.9× trailing earnings, well above its own five-year average of 10.5×: investors are paying up relative to the company's past. The Financial Services median in the September 2026 study was 13.1×. Forward P/E is 12.2×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.29**. A PEG of 0.29 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.1×**. Each dollar of revenue is priced at 1.1×.
- **Price / book: 4.1×**. The shares trade at 4.1× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 1.5×**. Enterprise value is 1.5× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 11.7%** (5-yr avg 39.4%). Free cash flow equals 11.7% of the market value, below its five-year average of 39.4%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 6.3%**. The inverse of the P/E: 6.3% of the price is earned each year.

## Profitability
- **Gross margin: 45.9%**. Marex Group Limited keeps 45.9% of revenue after the direct cost of what it sells.
- **Operating margin: 33.9%**. 33.9% of revenue is left after running the business, an exceptional level.
- **Net margin: 15.2%**. 15.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 26.4%**. 26.4% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: -77.3%**. Return on all capital, debt included, is -77.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 1.2%**. Each dollar of assets produces 1.2% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): 26.9%** (3-yr 41.7%/yr). Revenue grew 26.9% over the last year.
- **EPS growth (1 yr): 41.9%** (3-yr 41.6%/yr). Earnings per share rose 41.9%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 43.4%/yr**. Free cash flow has compounded at 43.4% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.
- **Cash and short-term investments: $2.9 billion**. Leverage ratios are shown differently for banks and insurers, whose balance sheets are built on deposits and reserves; use return on equity and the regulatory capital in the filings instead.

## Dividends
- **Dividend yield: 0.82%** ($0.75 per share, trailing). Marex Group Limited yields 0.82%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 18%** (8% of free cash flow). 18% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 2**. 2 straight years of increases.

## Price and momentum
- **Total return (1 yr): 122.8%** (YTD 105.5%, 3-mo 42.0%). The shares are up 122.8% over twelve months including dividends.
- **From 52-week high: -0.1%** (180.4% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 69**. An RSI of 69 is neutral.
- **Beta (1 yr): 0.74** (volatility 47%). Beta of 0.74 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MRX · Page: https://foliofundamentals.com/stocks/mrx

Not investment advice.